Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury

Anuradha Krishnan(Mayo Clinic), Gregory J. Gores(Mayo Clinic)
Scientific Reports
January 25, 2024
Cited by 7


Related Papers

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.4k
Cholangiocarcinoma
|Nature Reviews Disease Primers|2021|830
Lysosomes in cell death
|Oncogene|2004|709
Cholangiocarcinoma
|Hepatology|2008|689